Skip to main content
. Author manuscript; available in PMC: 2019 Aug 7.
Published in final edited form as: J Heart Valve Dis. 2014 Nov;23(6):713–720.

Table II:

Left ventricular volume and mitral regurgitation (MR) data.

Measurement Baseline 30 min post MI Eight weeks after MI
Resting Dobutamine 5 μg/kg/min Dobutamine 10 μg/kg/min
MR grade 0.7 ± 0.5 0.9 ± 0.7 2.0 ± 1.2a,b 2.6 ± 1.2a,b 2.6 ± 1.3a,b
LVEF (%) 40.3 ± 6.6 31.4 ± 5.8a 25.8 ± 7.7a 29.8 ± 7.5a 32.6 ± 10.7a
LVEDV (ml) 51.9 ± 8.7 57.9 ± 8.5 102.0 ± 24.1a,b 84.4 ± 24.0a,b,c 70.6 ± 19.1a,b,c,d
LVESV (ml) 31.2 ±6.8 39.8 ± 7.3a 75.8 ± 20.3a,b 59.6 ± 20.8a,b,c 47.7 ± 16.1a,c

All values are mean ± SD.

LVEDV: Left ventricular end-diastolic volume; LVEF: Left ventricular ejection fraction; LVESV: Left ventricular end-systolic volume; MI: Myocardial infarction.

a

p <0.05 versus baseline;

b

p <0.05 versus 30 min after MI;

c

p <0.05 versus resting condition,

d

p <0.05 versus dobutamine 5 μg/kg/min.